Brief: Radiopharm Theranostics Says U.S. FDA Grants Rare Pediatric Disease Designation For Dunp19
16/09/2022 10:03
Sept 16 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION FOR DUNP19
Source text for Eikon: ID:nASXg8Qzq
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%